Faculty
Lindsay A. Renfro
Contact
Texas Woman's University: Hallmark Alumni Award, 2018
Mayo Clinic: KL2 Mentored Career Development Award, 2015-2018
ENAR / International Biometric Society: Distinguished Student Paper Award, 2011
National Science Foundation, National Center for Education Statistics: Fellow, National Summer Data Policy Institute, 2010
Association for Institutional Research, National Center for Education Statistics: AIR/NCES Graduate Fellowship, 2008-2010
Association for Institutional Research: Best Paper Award, 2007
Baylor University: Dean's Stipend Enhancement Award, 2006-2011
Kappa Mu Epsilon National Mathematics Honor Society: Best Paper Award, 2005
Texas Woman's University: Chancellor's Research Scholar, 2005
Texas Woman's University: Harlan Miller Award and Memorial Scholarship, 2004-2005
Texas Instruments: Women in Engineering Award and Scholarship, 2003-2005
Texas Woman's University: Hallmark Alumni Award, 2018
Mayo Clinic: KL2 Mentored Career Development Award, 2015 - 2018
ENAR / International Biometric Society: Distinguished Student Paper Award, 2011
Baylor University: Dean's Stipend Enhancement Award, 2006 - 2011
National Science Foundation, National Center for Education Statistics: Fellow, National Summer Data Policy Institute, 2010
Association for Institutional Research, National Center for Education Statistics: AIR/NCES Graduate Fellowship, 2008 - 2010
Association for Institutional Research: Best Paper Award, 2007
Kappa Mu Epsilon National Mathematics Honor Society: Best Paper Award, 2005
Texas Woman's University: Chancellor's Research Scholar, 2005
Texas Woman's University: Harlan Miller Award and Memorial Scholarship, 2004 - 2005
Texas Instruments: Women in Engineering Award and Scholarship, 2003 - 2005
Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment Pharm Stat. 2024 Oct 24. . View in PubMed
Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma JCO Oncol Pract. 2024 Sep 20; OP2400089. . View in PubMed
Latest Developments in "Adaptive Enrichment" Clinical Trial Designs in Oncology Ther Innov Regul Sci. 2024 Sep 13. . View in PubMed
Long-term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study Int J Cancer. 2024 Jul 08. . View in PubMed
Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534 Pediatr Blood Cancer. 2024 Jul; 71(7):e30981. . View in PubMed
Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2 Cancer. 2024 Jul 01; 130(13):2361-2371. . View in PubMed
Biomarker-driven basket trial designs: origins and new methodological developments J Biopharm Stat. 2024 Jun 04; 1-13. . View in PubMed
Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2 J Am Coll Surg. 2024 Apr 01; 238(4):733-749. . View in PubMed
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532 Cancer. 2024 03 01; 130(5):792-802. . View in PubMed
Considerations on Design and Analysis of External Control in Pediatric Oncology Med Res Arch. 2024 Jan; 12(1). . View in PubMed
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5 Cancer. 2024 03 15; 130(6):947-961. . View in PubMed
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q Nat Commun. 2023 Dec 18; 14(1):8006. . View in PubMed
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study Res Sq. 2023 Mar 16. . View in PubMed
Children's Oncology Group's 2023 blueprint for research: Renal tumors Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30586. . View in PubMed
BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children's Oncology Group Study AREN03B2 Arch Pathol Lab Med. 2023 12 20. . View in PubMed
Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy J Clin Oncol. 2023 09 10; 41(26):4247-4256. . View in PubMed
Bayesian adaptive trial design for a continuous biomarker with possibly nonlinear or nonmonotone prognostic or predictive effects Biometrics. 2022 12; 78(4):1441-1453. . View in PubMed
Authors' Reply to the Letter to the Editor by Daniel MGreen. J Natl Compr Canc Netw. 2022 03; 20(3):xlvii-xlviii. . View in PubMed
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533 J Clin Oncol. 2022 09 10; 40(26):3047-3056. . View in PubMed
Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study Cell Rep Med. 2022 06 21; 3(6):100644. . View in PubMed
Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor J Natl Compr Canc Netw. 2021 08 01; 19(8):978-985. . View in PubMed
Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection Stat Med. 2020 08 30; 39(19):2568-2586. . View in PubMed
Reply to DM. Green. J Clin Oncol. 2020 03 01; 38(7):773-774. . View in PubMed
Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D3 levels and survival among patients with metastatic colorectal cancer Cancer Causes Control. 2019 Jul; 30(7):757-765. . View in PubMed
On the need to adjust for multiplicity in confirmatory clinical trials with master protocols Ann Oncol. 2019 04 01; 30(4):506-509. . View in PubMed
Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children's Oncology Group JCO Precis Oncol. 2019; 3. . View in PubMed
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer N Engl J Med. 2018 Mar 29; 378(13):1177-1188. . View in PubMed
Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database Eur J Cancer. 2018 11; 103:205-213. . View in PubMed
Definitions and statistical properties of master protocols for personalized medicine in oncology J Biopharm Stat. 2018; 28(2):217-228. . View in PubMed
Point estimation following two-stage adaptive threshold enrichment clinical trials Stat Med. 2018 09 30; 37(22):3179-3196. . View in PubMed
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project J Natl Cancer Inst. 2018 06 01; 110(6):638-648. . View in PubMed
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer Clin Cancer Res. 2018 01 15; 24(2):316-325. . View in PubMed
Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer J Clin Oncol. 2017 Aug 10; 35(23):2624-2630. . View in PubMed
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database J Clin Oncol. 2017 Jun 10; 35(17):1929-1937. . View in PubMed
Anorectal Function and Quality of Life in Patients With Early Stage Rectal Cancer Treated With Chemoradiation and Local Excision Dis Colon Rectum. 2017 May; 60(5):459-468. . View in PubMed
Prospective Evaluation of a 12-Gene Assay on Patient Treatment Decisions and Physician Confidence in Mismatch Repair Proficient Stage IIA Colon Cancer Clin Colorectal Cancer. 2017 03; 16(1):23-30. . View in PubMed
Precision oncology: A new era of cancer clinical trials Cancer Lett. 2017 02 28; 387:121-126. . View in PubMed
Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples Ann Oncol. 2017 01 01; 28(1):34-43. . View in PubMed
Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trials Chin Clin Oncol. 2016 Dec; 5(6):80. . View in PubMed
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database J Clin Oncol. 2016 Apr 10; 34(11):1182-9. . View in PubMed
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database J Clin Oncol. 2016 Mar 10; 34(8):843-53. . View in PubMed
Clinical trial designs incorporating predictive biomarkers Cancer Treat Rev. 2016 Feb; 43:74-82. . View in PubMed
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database J Clin Oncol. 2016 Jan 10; 34(2):144-50. . View in PubMed
Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database J Geriatr Oncol. 2016 11; 7(6):422-429. . View in PubMed
Surrogate End Points in Soft Tissue Sarcoma: Methodologic Challenges J Clin Oncol. 2016 11 10; 34(32):3949-3950. . View in PubMed
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial Lancet Oncol. 2015 Nov; 16(15):1537-1546. . View in PubMed
Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer J Thorac Oncol. 2015 Jul; 10(7):1099-106. . View in PubMed
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population† Ann Oncol. 2015 May; 26(5):950-958. . View in PubMed
Impact of Copula Directional Specification on Multi-Trial Evaluation of Surrogate End Points J Biopharm Stat. 2015; 25(4):857-77. . View in PubMed
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer Pharmacoeconomics. 2014 Dec; 32(12):1231-43. . View in PubMed
ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer J Natl Cancer Inst. 2014 Dec; 106(12). . View in PubMed
Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) CollaborationProjecting analysis dates for the IDEA collaboration. Forum Clin Oncol. 2014 Dec; 5(2):1-7. . View in PubMed
Center-Within-Trial Versus Trial-Level Evaluation of Surrogate Endpoints Comput Stat Data Anal. 2014 Oct 01; 78:1-20. . View in PubMed
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program J Clin Oncol. 2014 Sep 20; 32(27):2975-84. . View in PubMed
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer Gastroenterology. 2014 Sep; 147(3):637-45. . View in PubMed
Genetic markers of treatment response to tumour necrosis factor-a inhibitors in the treatment of psoriasis Clin Exp Dermatol. 2014 Jun; 39(4):519-24. . View in PubMed
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients Oncologist. 2014 May; 19(5):492-7. . View in PubMed
Adaptive randomized phase II design for biomarker threshold selection and independent evaluation Chin Clin Oncol. 2014 Mar 01; 3(1). . View in PubMed
Adaptive randomized phase II design for biomarker threshold selection and independent evaluation Chin Clin Oncol. 2014 Mar; 3(1):3. . View in PubMed
Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer PLoS One. 2014; 9(4):e94727. . View in PubMed
MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial PLoS One. 2014; 9(10):e108483. . View in PubMed
Mining the ACCENT database: a review and update Chin Clin Oncol. 2013 Jun; 2(2):18. . View in PubMed
Chronic consequences of acute injuries: worse survival after discharge J Trauma Acute Care Surg. 2012 Sep; 73(3):699-703. . View in PubMed
Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials Stat Med. 2012 Apr 13; 31(8):743-61. . View in PubMed
Bayesian adaptive trial design for a newly validated surrogate endpoint Biometrics. 2012 Mar; 68(1):258-67. . View in PubMed
Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis Br J Dermatol. 2010 Nov; 163(5):1056-63. . View in PubMed
Neutrophilic sebaceous adenitis Arch Dermatol. 1993 Jul; 129(7):910-1. . View in PubMed
Persistent plaque on the shoulder of a Chinese womanBCG granuloma. Arch Dermatol. 1993 Feb; 129(2):233236. . View in PubMed
Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser Arch Dermatol. 1993 Feb; 129(2):182-8. . View in PubMed
Painful nodules in a young femaleAntiphospholipid syndrome. Arch Dermatol. 1992 Jun; 128(6):847-8850-1. . View in PubMed
Lack of efficacy of the Q-switched ruby laser in the treatment of vitiligo Arch Dermatol. 1992 Feb; 128(2):277-8. . View in PubMed
Ulcerative lichen planus-like dermatitis associated with hydroxyurea J Am Acad Dermatol. 1991 Jan; 24(1):143-5. . View in PubMed